US 12,392,768 B2
Methods for determining blood gas or metabolic parameters
Thomas Steen Hansen, Brønshøj (DK); Ida Hollesen, Brønshøj (DK); and Melanie Andrea Burkhardt, Brønshøj (DK)
Assigned to RADIOMETER MEDICAL APS, (DK)
Appl. No. 17/606,511
Filed by RADIOMETER MEDICAL APS, Brønshøj (DK)
PCT Filed May 14, 2020, PCT No. PCT/EP2020/063409
§ 371(c)(1), (2) Date Oct. 26, 2021,
PCT Pub. No. WO2020/229580, PCT Pub. Date Nov. 19, 2020.
Claims priority of application No. PA 2019 00579 (DK), filed on May 14, 2019.
Prior Publication US 2022/0205975 A1, Jun. 30, 2022
Int. Cl. G01N 33/49 (2006.01); G01N 1/38 (2006.01); G01N 1/42 (2006.01); G01N 15/01 (2024.01); G01N 15/14 (2024.01)
CPC G01N 33/4925 (2013.01) [G01N 1/38 (2013.01); G01N 1/42 (2013.01); G01N 15/14 (2013.01); G01N 2015/016 (2024.01); G01N 2015/1486 (2013.01)] 20 Claims
OG exemplary drawing
 
14. An in vitro method for determining a BMP parameter in a blood sample comprising:
i) combining the blood sample with an anti-coagulant and an anti-platelet agent,
ii) exposing the blood sample to a temperature below 20° C., and
iii) determining said BMP parameter in the blood sample,
wherein the anti-coagulant is heparin and the antiplatelet agent is Iloprost, and
wherein the method does not comprise combining MgSO4, EDTA, or citrate with blood of the blood sample.